Oral Antibiotics Market, By Dosage Form (Tablet, Capsule, Oral suspension, Oral solution/ready-to-drink, and Granules/sachets), By Drug Class (Penicillins (Amoxicillin, Ampicillin, Others), Cephalosporins (Cephalexin, Cefpodoxime, Others), Macrolides (Azithromycin, Clarithromycin, Others), Lincosamides (Clindamycin), Tetracyclines (Doxycycline, Minocycline, Others), Fluoroquinolones (Ciprofloxacin, Levofloxacin, Others), Oxazolidinones (Linezolid, Tedizolid, Others), Sulfonamide (trimethoprim–sulfamethoxazole), Nitroimidazoles (Metronidazole, Tinidazole, Others), and Others (Rifamycins, Nitrofurans, Glycopeptides, Macrocyclics, etc.)), By Application (Respiratory tract infections, Skin and soft tissue infections, Urinary tract infections, Gastrointestinal/enteric infections, Sexually transmitted infections, Dental/orofacial infections, Clostridioides difficile infection, and Others (Mycobacterial infections)), By Release Profile (Immediate-release and Extended-release/delayed-release), By Spectrum of Activity (Broad-spectrum antibiotics and Narrow-spectrum antibiotics), By Patient Group (Adult, Pediatric, and Geriatric), By Prescription Type (Prescription Drugs and Over-the-Counter (OTC)), By Manufacturer Type (Branded and Generics), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)
선택하다 귀사의 비즈니스 요구 사항에 맞는 라이센스 유형
US$ 2,200
이천이백 달러
단일 사용자 라이센스
( 전체 보고서 )
US$ 4,500
US$ 3,000
Three thousand dollars
자주 구매되는 상품
다중 사용자 라이센스
(전체 보고서)
US$ 7,000
US$ 5,000
Five thousand dollars
기업 사용자 라이센스
(전체 보고서)
US$ 10,000
US$ 6000
Six thousand dollars
Client Testimonials
Client Testimonials
우리의 고객